Endotronix Celebrates 100th Implant Of The Cordella Pulmonary Artery Pressure Sensor For Proactive, Remote Management Of Heart Failure
Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced the 100th global implant of the Cordella Pulmonary Artery Pressure Sensor (Cordella Sensor) by Cardiologist and top worldwide implanter Faisal Sharif, MD of Bon Secours Hospital and Director of Cardiovascular Research at NUIG, both in Galway, Ireland. Read More →
Western Ireland’s University Hospital Galway Leading Advanced Heart Failure Monitoring Clinical Trial
The investigational product, known as the Cordella Sensor from U.S.-based company called Endotronix, detects changes in the health of patients with heart failure while securely transmitting information to the cardiovascular team. With this data in real time, the cardiovascular team can not only receive relevant updates but also can intervene with the goal of preventing heart failure flare-up resulting in emergency hospitalization.
Read More →
Endotronix begins heart failure study with Cordella Sensor
Digital health and medical technology firm Endotronix has recruited the first two patients in the PROACTIVE-HF pivotal trial of the Cordella pulmonary artery (PA) pressure sensor system.
Read More →
Endotronix begins heart failure study with Cordella Sensor
By NS Medical Staff Writer Digital health and medical technology firm Endotronix has recruited the first two patients in the PROACTIVE-HF pivotal trial of the Cordella pulmonary artery (PA) pressure sensor system. The pre-market investigational device exempt (IDE) trial has been... Read More →
Endotronix unveils positive data from SIRONA trial of Cordella system
Endotronix’ Cordella heart failure system is intended to help patients suffering from chronic heart failure to stay out of the hospital Image: Cordella system provides complete health status of the patient at home. Photo: Courtesy of Reaper DZ from Pixabay.... Read More →
Mansueto, Polsky part of $25 million medical-device investment
Endotronix raised another $25 million to conduct late-stage trials of an implantable device to help doctors better monitor cardiac patients and detect problems before they lead to heart failure. The Lisle-based company raised $45 million a year ago in preparation for trials in... Read More →
Endotronix Enrolls First Patient in SIRONA II CE Mark Trial
LISLE, Ill., July 15, 2019 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, in Europe. The 60-patient study will evaluate safety... Read More →